Future Therapies of Wet Age-Related Macular Degeneration
Joint Authors
Yoshitomi, Takeshi
Jin, Daisuke
Sawada, Yu
Abe, Sanae
Ishikawa, Makoto
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-02-24
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population, and the prevalence of the disease increases exponentially with every decade after the age of 50 years.
While VEGF inhibitors are promising drugs for treating patients with ocular neovascularization, there are limitations to their potential for improving vision in AMD patients.
Thus, future therapies are required to have the potential to improve visual outcomes.
This paper will summarize the future strategies and therapeutic targets that are aimed at enhancing the efficacy and duration of effect of antiangiogenic strategies.
American Psychological Association (APA)
Ishikawa, Makoto& Jin, Daisuke& Sawada, Yu& Abe, Sanae& Yoshitomi, Takeshi. 2015. Future Therapies of Wet Age-Related Macular Degeneration. Journal of Ophthalmology،Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1069647
Modern Language Association (MLA)
Ishikawa, Makoto…[et al.]. Future Therapies of Wet Age-Related Macular Degeneration. Journal of Ophthalmology No. 2015 (2015), pp.1-10.
https://search.emarefa.net/detail/BIM-1069647
American Medical Association (AMA)
Ishikawa, Makoto& Jin, Daisuke& Sawada, Yu& Abe, Sanae& Yoshitomi, Takeshi. Future Therapies of Wet Age-Related Macular Degeneration. Journal of Ophthalmology. 2015. Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1069647
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1069647
